Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;35(3):303-312.
doi: 10.14670/HH-18-174. Epub 2019 Oct 21.

Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration

Zhiqiang Wu #  1   2 , Zhengwang Sun #  1   2 , Rui Huang #  3 , Ding Zang #  4 , Chunmeng Wang  1   2 , Xu Yan  5 , Wangjun Yan  2   6
Affiliations

Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration

Zhiqiang Wu et al. Histol Histopathol. 2020 Mar.

Abstract

Background: Synaptotagmin 7 (SYT7) is a component of the synaptotagmin family, which is essential in many physiological and pathological processes. In this study, we aimed to investigate the role of SYT7 in osteosarcoma.

Methods: We defined the expression levels of SYT7 in osteosarcoma tissues and para-sarcoma tissues by immunohistochemistry and analyzed the possible correlation between SYT7 expression and pathological characteristics via Mann-Whitney U analysis and Spearman correlation analysis. The effects of SYT7 silencing in vitro cell growth were assessed by MTT assay. Cell cycle and cell apoptosis were assessed by flow cytometry analysis. Wound healing assay and transwell assay were applied to assess the migration and invasion capacity.

Results: The results showed that the expression levels of SYT7 were upregulated in osteosarcoma tissues compared with para-sarcoma tissues and positively correlated with the pathological characteristics of osteosarcoma. Functional experiments demonstrated that SYT7 silencing significantly inhibited cell proliferation and colony formation capacity (P<0.001), induced cell cycle arrest which increased the proportion of G2 phase and decreased the proportion of S phase, enhanced cell apoptosis (P<0.01), and limited the capacity of migration and invasion (P<0.01), compared with shCtrl group.

Conclusion: The results indicated that SYT7 plays a crucial role in the development of osteosarcoma. SYT7 can be applied as a new diagnostic and therapeutic target in osteosarcoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Botter S.M., Neri D. and Fuchs B. (2014). Recent advances in osteosarcoma. Curr. Opin. Pharmacol. 16, 15-23. - PubMed
    1. Chapman E.R. (2008). How does synaptotagmin trigger neurotransmitter release? Annu. Rev. Biochem. 77, 615-641. - PubMed
    1. Colvin R.A., Means T.K., Diefenbach T.J., Moita L.F., Friday R.P., Sever S., Campanella G.S., Abrazinski T., Manice L.A., Moita C., Andrews N.W., Wu D., Hacohen N. and Luster A.D. (2010). Synaptotagminmediated vesicle fusion regulates cell migration. Nat. Immunol. 11, 495-502. - PMC - PubMed
    1. Del Mare S. and Aqeilan R.I. (2015). Tumor suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function. Sci. Rep. 5, 12959. - PMC - PubMed
    1. Dong Y., Liang G., Yuan B., Yang C., Gao R. and Zhou X. (2015). MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 36, 1477- 1486. - PubMed

Grants and funding

LinkOut - more resources